Downregulation of miR-203a-3p in MM-MSCs led to the promotion of osteogenesis by upregulation of SMAD8, followed by an increase in the mRNA expression levels of osteoblastic differentiation markers such as ALPL, OC, OPN [64]. The gene discussed is ALPL; the disease is Miyoshi myopathy.